• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Nov26
Distribution Plan(EST)

Cash dividend 0.0711 USD

Nov25
Distribution Plan(EST)

Cash dividend 0.0711 USD

Distribution Plan(EST)

Cash dividend 0.0711 USD

View More

Event Tracking

Dec6
Takeda and Protagonist Announce 52-Week Data for Rusfertide and Plan to Seek Regulatory Approval
14:30
Nov27
Protagonist Therapeutics Sees Significant Revenue Growth with Janssen Collaboration
22:45
Nov24
Roth MKM analyst maintains buy rating on Clearway Energy
05:36
Nov14
H.C. Wainwright Analyst Reiterates Buy Rating on Protagonist Therapeutics
23:42
Ezcorp released FY2025 Q4 earnings on November 13 After-Market EST, actual revenue USD 336.81 M (forecast USD 325.4 M), actual EPS USD 0.3435 (forecast USD 0.2966)
00:00
Ezcorp released FY2025 annual earnings on November 13 After-Market EST, actual revenue USD 1.274 B (forecast USD 1.263 B), actual EPS USD 1.42 (forecast USD 1.3483)
00:00